MLH1 and colorectal carcinoma: Of the 422/2204 (19.15%) CRC samples showing IHC loss, 67 (15.9%) were explained by MLH1 promotor methylation; 155 (36.7%) had a germline path_MMR; and 65 (15.4%) showed evidence of somatic involvement of the relevant gene.